Search company, investor...
Insulet company logo

Insulet

insulet.com

Founded Year

2000

Stage

IPO | IPO

Total Raised

$119.5M

Date of IPO

11/19/2007

Market Cap

19.83B

Stock Price

286.20

About Insulet

Insulet is a medical device manufacturer that aims to improve the lives of people with diabetes.

Headquarters Location

9 Oak Park Drive

Bedford, Massachusetts, 01730,

United States

781-457-5000

Missing: Insulet's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Insulet's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Insulet

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Insulet is included in 3 Expert Collections, including Diabetes.

D

Diabetes

1,903 items

M

Medical Devices

3,567 items

https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.

B

Biopharma Tech

260 items

Insulet Patents

Insulet has filed 197 patents.

The 3 most popular patent topics include:

  • Drug delivery devices
  • Medical equipment
  • Insulin therapies
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/11/2020

1/10/2023

Diabetes, Insulin therapies, Diets, Nutrition, Obesity

Grant

Application Date

2/11/2020

Grant Date

1/10/2023

Title

Related Topics

Diabetes, Insulin therapies, Diets, Nutrition, Obesity

Status

Grant

Latest Insulet News

Omnipod Customers’ PHI Potentially Leaked

Jan 27, 2023

January 27, 2023 Insulet announced that it has emailed 29,000 Omnipod insulin pump customers to advise them that some of their personal health information (PHI) — but not financial, social security number, email or password — was inadvertently shared with Insulet’s website performance and marketing partners. Around Dec. 1, 2022, Insulet said it sent customers a Medical Device Correction (MDC) email which included a clickable URL response link for the customer to acknowledge receipt of the email. The link included the customer’s IP address, whether the customer is an Omnipod DASH insulin management system user and whether the customer has a personal diabetes manager. The company said the data exposure happened because the URLs “were shared with website performance and marketing partners of Insulet through website ‘cookies’ and/or other trackers embedded in the omnipod.com website code on the MDC acknowledgment web page.” Insulet said it discovered the issue on Dec. 6 and disabled the tracking codes so no further data would be exposed and requested that its partners delete their logs of IP addresses and URLs. — Karen Early

Insulet Frequently Asked Questions (FAQ)

  • When was Insulet founded?

    Insulet was founded in 2000.

  • Where is Insulet's headquarters?

    Insulet's headquarters is located at 9 Oak Park Drive, Bedford.

  • What is Insulet's latest funding round?

    Insulet's latest funding round is IPO.

  • How much did Insulet raise?

    Insulet raised a total of $119.5M.

  • Who are the investors of Insulet?

    Investors of Insulet include Prism VentureWorks, SV Health Investors, Versant Ventures, Pequot Venture Capital, SightLine Partners and 14 more.

  • Who are Insulet's competitors?

    Competitors of Insulet include MedicSen and 1 more.

Compare Insulet to Competitors

Hedia Logo
Hedia

Hedia is a mobile application that aims to make life easier for those with diabetes. Hedia can calculate exactly how much insulin an individual needs based on their carbohydrate intake and activity level. The app subsequently remembers this data in order to keep track of how much active insulin remains in the body, meaning Hedia learns the user's insulin needs and habits over time.

DigiBete Logo
DigiBete

DigiBete is a digital video platform to support self-care and virtual clinics for children and young people with diabetes. It was founded in 2016 and is based in Leeds, England.

Retinai Logo
Retinai

Retinai supports eye care professionals and patients throughout the medical examination process using Artificial Intelligence. Its vision is to foster the transition from reactive medicine to preventive medicine for high-impact diseases such as age-related Macular Degeneration, Diabetic Retinopathy, and Glaucoma. Its solutions rely on advances in medical image analysis, opthalmology, and machine learning.

Suvera Logo
Suvera

Suvera is a technology and virtual healthcare solution company. It aims to reduce the workload and waiting times at physical clinics by providing services virtually, such as administering prescriptions and tracking blood pressure results. It provides services remotely for patients with long-term chronic conditions like diabetes and hypertension. The company was founded in 2019 and is based in Spitalfields, U.K.

LetsGetChecked Logo
LetsGetChecked

LetsGetChecked offers at-home tests for a variety of conditions. The company builds and delivers at-home testing kits, including hormone tests, fertility tests, HPV tests and wellness tests for cholesterol or diabetes. Its services includes manufacturing, logistics, lab analysis, clinician support, and prescription fulfillment. The company was founded in 2015 and is based in Dublin, Ireland.

Changing Health Logo
Changing Health

Changing Health provides digital education and personalized coaching to help people with Type 2 diabetes control their symptoms using research to develop behavioral change techniques.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.